Monitoring Movement Disorder Symptoms With a Mobile Medical App on Off-the-shelf Consumer Mobile Devices

Parkinson's & Movement Disorders Center of Maryland100 enrolled

Overview

The purpose of this study is to evaluate whether New Touch Digital (NTD) NeuroRPM software installed on wearable devices can objectively measure and track symptoms in patients with Parkinson's disease.

Study Type

OBSERVATIONAL

Enrollment

100

Conditions

Parkinson Disease

Interventions

Monitoring DeviceDEVICE

Monitoring Device

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Subject is 18 years of age or older 2. Subject is able to provide informed written consent 3. Subject has been clinically diagnosed with Parkinson's Disease 4. Subject is mentally and physically capable of performing tasks on the mobile device and related physical activities herein described Exclusion Criteria: 1. Inability to give informed consent 2. Presence of additional neurological disease aside from the diseases being studied 3. Inability to understand and follow the directions for the study

Locations (1)

Parkinson's & Movement Disorders Center of Maryland

Elkridge, Maryland, United States

Outcomes

Primary Outcomes

NeuroRPM UPDRS predicted score vs. clinical raters' UPDRS

We will compare symptom severity as predicted by NeuroRPM to UPDRS scores from clinical raters. Statistical significance will be evaluated by intraclass correlation and kappa-statistic.

Time frame: Comparison will be performed upon completion of the study, approximately in 1 year.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.